ALLMedicine™ Acetoacetate Center
Research & Reviews 204 results
https://clinicaltrials.gov/ct2/show/NCT04760847
Mar 10th, 2023 - Fasting is a classic means for religious discipline, yet recently regaining favor in the medical landscape. Numerous studies have come forth, both in animals and humans outlining the benefit of intermittent fasting (IF) on various disease states a...
http://emedicine.medscape.com/article/946234-overview
Feb 28th, 2023 - Background Maple syrup urine disease (MSUD), also known as branched-chain ketoaciduria, is an aminoacidopathy due to an enzyme defect in the catabolic pathway of the branched-chain amino acids leucine, isoleucine, and valine. Accumulation of these...
https://emedicine.medscape.com/article/946234-overview
Feb 28th, 2023 - Background Maple syrup urine disease (MSUD), also known as branched-chain ketoaciduria, is an aminoacidopathy due to an enzyme defect in the catabolic pathway of the branched-chain amino acids leucine, isoleucine, and valine. Accumulation of these...
https://emedicine.medscape.com/article/946234-print
Feb 28th, 2023 - Background Maple syrup urine disease (MSUD), also known as branched-chain ketoaciduria, is an aminoacidopathy due to an enzyme defect in the catabolic pathway of the branched-chain amino acids leucine, isoleucine, and valine. Accumulation of these...
https://clinicaltrials.gov/ct2/show/NCT03560323
Feb 21st, 2023 - Purpose/Objectives The EMPA-REG OUTCOME (NCT01131676) trial demonstrated that SGLT2 (sodium-glucose co-transporter) inhibition with empagliflozin markedly reduced cardiovascular (CV) mortality and hospitalization for heart failure. In diabetic pat...
Clinicaltrials.gov 34 results
https://clinicaltrials.gov/ct2/show/NCT04760847
Mar 10th, 2023 - Fasting is a classic means for religious discipline, yet recently regaining favor in the medical landscape. Numerous studies have come forth, both in animals and humans outlining the benefit of intermittent fasting (IF) on various disease states a...
https://clinicaltrials.gov/ct2/show/NCT03560323
Feb 21st, 2023 - Purpose/Objectives The EMPA-REG OUTCOME (NCT01131676) trial demonstrated that SGLT2 (sodium-glucose co-transporter) inhibition with empagliflozin markedly reduced cardiovascular (CV) mortality and hospitalization for heart failure. In diabetic pat...
https://clinicaltrials.gov/ct2/show/NCT05654909
Feb 16th, 2023 - The demand for healthcare is increasing, stressing the need for adaptive Emergency Medical Services (EMS). This development was also illustrated in a Danish cohort study from 2017. The authors reported an increase in the annual number of patients ...
https://clinicaltrials.gov/ct2/show/NCT04421014
Feb 3rd, 2023 - Study Description: We hypothesize that supplementation with a ketone ester drink [Ketone Ester (KE)] compared to placebo, in cognitively intact adults >= 55 years old with Metabolic Syndrome (MetS), will (i) increase peripheral and brain ketone le...
https://clinicaltrials.gov/ct2/show/NCT05238805
Jan 18th, 2023 - Healthy people will have two positron emission tomography scan to perform. One, with a 11C-Acetate Tracer and the other with 11C-Acetoacetate. The results will allow to determine if both tracers are used in a similar way but the organs and see if ...
News 4 results
https://www.medscape.com/viewarticle/960040
Sep 30th, 2021 - Circulating ketone bodies (KBs) are substantially elevated at presentation and 24 hours after ST-segment elevation myocardial infarction (STEMI), according to new research. The study also showed that greater KB levels measured after 24 hours of re...
https://www.mdedge.com/endocrinology/article/109401/diabetes/liraglutide-prevents-ketogenesis-type-1-diabetes
Daniel M. Keller
Jun 3rd, 2016 - ORLANDO – A single injection of liraglutide can prevent ketogenesis in fasting patients with type 1 diabetes who were on basal insulin, findings from a small study have shown. Husam Ghanim, Ph.
https://www.mdedge.com/clinicianreviews/article/109452/diabetes/liraglutide-prevents-ketogenesis-type-1-diabetes
Daniel M. Keller
Jun 3rd, 2016 - ORLANDO – A single injection of liraglutide can prevent ketogenesis in fasting patients with type 1 diabetes who were on basal insulin, findings from a small study have shown. Husam Ghanim, Ph.
https://www.medscape.com/viewarticle/871633_5
Which Pathophysiologic Factors Contribute to SGLT-2 Inhibitor–Associated DKA? Ketones such as acetoacetate and β-hydroxybutyrate are acidic alternate fuel molecules produced in the liver through the oxidation of fatty acids when dietary carbohydra...